Taylor Andrew Lawrence 4
4 · Orchestra BioMed Holdings, Inc. · Filed Dec 20, 2024
Insider Transaction Report
Form 4
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2024-12-19$4.83/sh+1,000$4,830→ 344,960 total
Footnotes (1)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.81 to $4.89. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.